Alexey L. Margolin, Chief Scientific Officer at Altus Pharmaceuticals Inc. (ALTU), sold 6,250 shares at $17.29 ($109K) on 2007-02-21, disclosed to the SEC on 2007-02-21.
Scheduled sale ($109k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.37 | 5,650 | $98K | 90.4% |
| 2 | $17.29 | 600 | $10K | 9.6% |
| Total | $17.36 avg | 6,250 | $109K | 100% |
| Filing → |
| ALTU | SELL | 2007-03-26 | $50K | — | Filing → |
| ALTU | SELL | 2007-03-19 | $47K | — | Filing → |
| ALTU | SELL | 2007-03-06 | $44K | — | Filing → |